CRON
Cronos Group, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · CA
$3.35
−0.59%Next report
Analyst consensus
- Next report date
- Nov 5, 2026
- EPS estimate
- $0.03
- Revenue estimate
- $49.5M
Latest reported
- Last report date
- Aug 6, 2026
- EPS actual
- $0.09
- EPS estimate
- $0.01
- Revenue actual
- $53.0M
- Revenue estimate
- $44.2M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 3
- EPS misses (12Q)
- 7
- EPS in line (12Q)
- 2
- Avg surprise (4Q)
- +162.5%
- Revenue beats (12Q)
- 5
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 6, 2026 | $0.01 | $0.09 | Beat 800.00% | $53.0M |
| May 11, 2026 | $0.01 | $0.01 | In line | $45.2M |
| Nov 6, 2025 | $0.02 | $0.07 | Beat 250.00% | $36.3M |
| Aug 7, 2025 | -$0.02 | -$0.10 | Miss -400.00% | $32.4M |
| May 8, 2025 | -$0.01 | $0.02 | Beat 378.55% | $22.7M |
| Feb 27, 2025 | -$0.01 | -$0.01 | In line | $21.1M |
| Aug 8, 2024 | -$0.00 | -$0.02 | Miss -700.00% | $20.3M |
| May 9, 2024 | -$0.01 | -$0.01 | Miss -25.00% | $18.5M |
| Feb 29, 2024 | -$0.01 | -$0.05 | Miss -233.33% | $18.5M |
| Feb 28, 2023 | -$0.05 | -$0.14 | Miss -180.00% | $17.1M |
| Mar 1, 2022 | -$0.10 | -$0.36 | Miss -260.00% | $20.2M |
| Aug 6, 2021 | -$0.07 | -$0.09 | Miss -28.57% | $12.6M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 5, 2026